Cui S - Search Results

1

A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer.

Zhang S, Zhang C, Liu J, Qin L, Cui S, Zhang J. Zhang S, et al. Among authors: cui s. Med Oncol. 2012 Jun;29(2):479-85. doi: 10.1007/s12032-011-9883-2. Epub 2011 Mar 6. Med Oncol. 2012. PMID: 21380781 Clinical Trial.

2

[Predicative value of 99mTc-MIBI scintimammography in neoadjuvant chemotherapeutic effect of patients with operable breast cancer].

Liu ZZ, Lu ZD, Liu H, Li LF, Zhang HW, Yang H, Li WL, Cui SD. Liu ZZ, et al. Zhonghua Yi Xue Za Zhi. 2011 Feb 15;91(6):382-4. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418909 Chinese.

3

High risk factors of brain metastases in 295 patients with advanced breast cancer.

Yan M, Lü HM, Liu ZZ, Liu H, Zhang MW, Sun XB, Cui SD. Yan M, et al. Chin Med J (Engl). 2013 Apr;126(7):1269-75. Chin Med J (Engl). 2013. PMID: 23557557

4

[Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients].

Jiao D, Qiao J, Lu Z, Li L, Zhang H, Liu H, Cui S, Liu Z. Jiao D, et al. Among authors: cui s. Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):198-201. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 24785280 Chinese.

5

[Influencing factors of pathologic complete response after neoadjuvant chemotherapy in locally advanced breast cancer patients: results of a single-center 10-year retrospective study].

Qiao J, Jiao D, Lu Z, Zhu J, Cui S, Liu Z. Qiao J, et al. Among authors: cui s. Zhonghua Yi Xue Za Zhi. 2014 May 13;94(18):1401-4. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25142991 Chinese.

6

A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy.

Qin L, Wang CZ, Fan HJ, Zhang CJ, Zhang HW, Lv MH, Cui SD. Qin L, et al. Oncol Lett. 2014 Nov;8(5):2000-2006. doi: 10.3892/ol.2014.2449. Epub 2014 Aug 14. Oncol Lett. 2014. PMID: 25289086 Free PMC article.

7

Expression of hepatocyte growth factor in breast cancer and its effect on prognosis and sensitivity to chemotherapy.

Yang H, Zhang C, Cui S. Yang H, et al. Among authors: cui s. Mol Med Rep. 2015 Feb;11(2):1037-42. doi: 10.3892/mmr.2014.2808. Epub 2014 Oct 29. Mol Med Rep. 2015. PMID: 25351134

8

Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer.

Mao Q, Li L, Zhang C, Sun Y, Liu S, Cui S. Mao Q, et al. Among authors: cui s. Pak J Pharm Sci. 2015 May;28(3 Suppl):1055-8. Pak J Pharm Sci. 2015. PMID: 26051718

9

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial.

Huang L, Chen S, Yang W, Xu B, Huang T, Yang H, Zheng H, Wang Y, Song E, Zhang J, Cui S, Pang D, Tang L, Lei Y, Geng C, Shao Z. Huang L, et al. Among authors: cui s. Oncotarget. 2015 Jul 30;6(21):18683-92. doi: 10.18632/oncotarget.4337. Oncotarget. 2015. PMID: 26084292 Free PMC article. Clinical Trial.

10

The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?

Sun Y, Liu X, Cui S, Li L, Tian P, Liu S, Li Y, Yin M, Zhang C, Mao Q, Wang J. Sun Y, et al. Among authors: cui s. Tumour Biol. 2016 Jul;37(7):9555-63. doi: 10.1007/s13277-016-4844-1. Epub 2016 Jan 20. Tumour Biol. 2016. PMID: 26790445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,095 results

Search Page

Filters